Detail page

Knowledge Web

Person

Fabian Beier (1979-)

Arzt

Name	Fabian Beier
Time	1979- (Date of birth and death)
Place	Filderstadt (Geburtsort) Deutschland
Gender	männlich
Academic degree	Dr. med. habil.
Profession	Arzt (characteristic profession)
Variant	F. Beier Fabian Johannes Alfred Beier (vollständiger Name)
Further information	Habilitationsschrift an der Rheinisch-Westfälischen Technischen Hochschule Aachen, Medizinische Fakultät, 2018; Facharzt für Hämatologie, Onkologie und Innere Medizin. Dissertation an der Universität Tübingen, Medizinische Fakultät, 2009
Source	Lebenslauf in der Habilitationsschrift
Record type	Person
GND-Identifier	138749027
Record ID	138749027
Involved in show all Harnessing CD3 diversity to optimize CAR T cells Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms Atgam - Antithymozytenglobulin bei aplastischer Anämie Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms Eltrombopag Preserves the Clonogenic Potential of Hematopoietic Stem Cells During Treatment With Antithymocyte Globulin in Patients With Aplastic Anemia Germline landscape of RPA1, RPA2 and RPA3 variants in pediatric malignancies : identification of RPA1 as a novel cancer predisposition candidate gene Hämolytische und aplastische Anämien als Erkrankungen aus dem Formenkreis der klassischen Hämatologie Harnessing CD3 diversity to optimize CAR T cells Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients Peripheral blood CD3+HLADR+ cells and associated gut microbiome species predict response and overall survival to immune checkpoint blockade The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1) Impaired overall survival in young patients with acute myeloid leukemia and variants in genes predisposing for myeloid malignancies Impaired Overall Survival in Young Patients With Acute Myeloid Leukemia and Variants in Genes Predisposing for Myeloid Malignancies P771: Prognostic characteristics of patients with MDS with aberrations of chromosome 5. Data from the Düsseldorf MDS registry Transient elastography in adult patients with cryptic dyskeratosis congenita reveals subclinical liver fibrosis: a retrospective analysis of the Aachen telomere biology disease registry Investigation of measurable residual disease in acute myeloid leukemia by DNA methylation patterns Selective ABO immunoadsorption in hematopoietic stem cell transplantation with major ABO incompatibility Transient elastography in adult patients with cryptic dyskeratosis congenita reveals subclinical liver fibrosis : a retrospective analysis of the Aachen telomere biology disease registry Revesz syndrome revisited PRDM8 reveals aberrant DNA methylation in aging syndromes and is relevant for hematopoietic and neuronal differentiation Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenita Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenita Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenita Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis Congenita Comparison of flow-FISH and MM-qPCR telomere length assessment techniques for the screening of telomeropathies Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita Klinische Manifestationen und Therapieoptionen bei Telomererkrankungen Presence of TERT Promoter Mutations is a Secondary Event and Associates with Elongated Telomere Length in Myxoid Liposarcomas Evidence for a pre-existing telomere deficit in non-clonal hematopoietic stem cells in patients with acute myeloid leukemia The atypical kinase RIOK1 promotes tumor growth and invasive behavior A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition Untersuchung zur Telomerbiologie hämatopoetischer Zellen in Patienten mit paroxysmaler nächtlicher Hämoglobinurie (PNH) mittels Proaerolysin multi-color flow-FISH Untersuchung zur Telomerbiologie hämatopoetischer Zellen in Patienten mit paroxysmaler nächtlicher Hämoglobinurie (PNH) mittels Proaerolysin multi-color flow-FISH

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Fabian Beier (1979-)

Harnessing CD3 diversity to optimize CAR T cells

Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms

Atgam - Antithymozytenglobulin bei aplastischer Anämie

Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms

Eltrombopag Preserves the Clonogenic Potential of Hematopoietic Stem Cells During Treatment With Antithymocyte Globulin in Patients With Aplastic Anemia

Germline landscape of RPA1, RPA2 and RPA3 variants in pediatric malignancies : identification of RPA1 as a novel cancer predisposition candidate gene

Hämolytische und aplastische Anämien als Erkrankungen aus dem Formenkreis der klassischen Hämatologie

Harnessing CD3 diversity to optimize CAR T cells

Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria

Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients

Peripheral blood CD3+HLADR+ cells and associated gut microbiome species predict response and overall survival to immune checkpoint blockade

The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling

Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1)

Impaired overall survival in young patients with acute myeloid leukemia and variants in genes predisposing for myeloid malignancies

Impaired Overall Survival in Young Patients With Acute Myeloid Leukemia and Variants in Genes Predisposing for Myeloid Malignancies

P771: Prognostic characteristics of patients with MDS with aberrations of chromosome 5. Data from the Düsseldorf MDS registry

Transient elastography in adult patients with cryptic dyskeratosis congenita reveals subclinical liver fibrosis: a retrospective analysis of the Aachen telomere biology disease registry

Investigation of measurable residual disease in acute myeloid leukemia by DNA methylation patterns

Selective ABO immunoadsorption in hematopoietic stem cell transplantation with major ABO incompatibility

Transient elastography in adult patients with cryptic dyskeratosis congenita reveals subclinical liver fibrosis : a retrospective analysis of the Aachen telomere biology disease registry

Revesz syndrome revisited

PRDM8 reveals aberrant DNA methylation in aging syndromes and is relevant for hematopoietic and neuronal differentiation

Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation

Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenita

Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenita

Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenita

Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis Congenita

Comparison of flow-FISH and MM-qPCR telomere length assessment techniques for the screening of telomeropathies

Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita

Klinische Manifestationen und Therapieoptionen bei Telomererkrankungen

Presence of TERT Promoter Mutations is a Secondary Event and Associates with Elongated Telomere Length in Myxoid Liposarcomas

Evidence for a pre-existing telomere deficit in non-clonal hematopoietic stem cells in patients with acute myeloid leukemia

The atypical kinase RIOK1 promotes tumor growth and invasive behavior

A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition

Untersuchung zur Telomerbiologie hämatopoetischer Zellen in Patienten mit paroxysmaler nächtlicher Hämoglobinurie (PNH) mittels Proaerolysin multi-color flow-FISH

Untersuchung zur Telomerbiologie hämatopoetischer Zellen in Patienten mit paroxysmaler nächtlicher Hämoglobinurie (PNH) mittels Proaerolysin multi-color flow-FISH